Screening for Coronary Artery Disease in Asymptomatic Diabetic Patients

Screening for Coronary Artery Disease in Asymptomatic Diabetic Patients

European Cardiovascular Disease 2007
Published: June 2007
dots

Improved Outcome
Finally, the screening algorithm should result in the alteration of individual treatment strategies and lead to improved outcome. Although data from the general population suggest that revascularisation or antiischaemic therapy should also be attractive in asymptomatic patients with diabetes, hard evidence is currently lacking. Preliminary data in small patient populations, however, are promising. Sorajja and colleagues observed in 261 asymptomatic diabetic patients with high-risk SPECT studies that revascularisation was independently associated with improved survival.11 Larger prospective studies are currently in progress and their observations are eagerly awaited.

Summary
A growing need exists to establish a clinical strategy for the cardiac evaluation and management of asymptomatic patients with diabetes. Although results from individual studies show a wide variation in exact numbers, the currently available data do suggest a significant prevalence of undiagnosed CAD in this population, which may warrant screening. To this purpose, sequential imaging of atherosclerosis and ischaemia could be a promising strategy. However, both safety and cost-effectiveness remain to be further evaluated. Whether screening and early detection of disease ultimately result in improved outcome has not yet been established.

References:
  1. http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Accessed 28 August 2006.
  2. Nesto RW, Phillips RT, Kett KG, et al., Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy, Ann Intern Med, 1988;108:170–75.
  3. Scognamiglio R, Negut C, Ramondo A, et al., Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus, J Am Coll Cardiol, 2006;47:65–71.
  4. Wackers FJ, Young LH, Inzucchi SE, et al., Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study, Diab Care, 2004;27:1954–61.
  5. Zellweger MJ, Hachamovitch R, Kang X, et al., Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients, Eur Heart J, 2004;25: 543–50.
  6. Rajagopalan N, Miller TD, Hodge DO, et al., Identifying highrisk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging, J Am Coll Cardiol, 2005;45:43–9.
  7. De Lorenzo A, Lima RS, Siqueira-Filho AG, et al., Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease, Am J Cardiol, 2002;90:827–32.
  8. Anand DV, Lim E, Lahiri A, et al., The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects, Eur Heart J, 2006;27:905–12.
  9. Anand DV, Lim E, Hopkins D, et al., Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy, Eur Heart J, 2006;27: 713–21.
  10. Scholte AJ, Bax JJ, Wackers FJ, Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring, J Nucl Cardiol, 2006;13:11–18.
  11. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al., Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting, Circulation, 2006;112:I311–16.

Copyright® 2010 Business Briefings, Ltd. All rights reserved.
Touch Cardiology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.